Abstract
Purpose
The current study was designed to analyze the impact of the COVID-19 pandemic on general thoracic surgeries in Japan.
Methods
Changes in surgeries for lung cancer and metastatic lung tumors were evaluated based on National Clinical Database data regarding cancer screening.
Results
In 2021, surgeries for primary lung cancer increased by 3.4% compared to 2020, which, given the increase from 2014 to 2019, indicates an overall 11.1% decrease. In contrast, surgeries for metastatic lung tumors in 2021 decreased by 5.8% compared to 2020, which, given the increase from 2014 to 2020, indicates an overall 9.2% decrease. Half of the primary diseases for metastatic lung tumor were cases of colorectal cancer. Low anterior resection procedures in 2020 decreased by 5.5% compared to 2019. Lung and colon cancer screening examinees in 2021 were increased compared to 2020; however, they still showed respective decreases of 11% and 9.0% compared to 2019.
Conclusions
Surgeries for primary lung cancer still decreased substantially during the COVID-19 pandemic. The continued stagnation of screening was responsible for this decrease. Surgeries for metastatic lung tumors decreased profoundly, and the decrease in screening for primary tumors was responsible for this reduction. Our findings emphasize the significance of maintaining cancer screening efforts, even during a pandemic.
Similar content being viewed by others
References
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.
Sato Y, Yamamoto H, Ikeda N, Konishi H, Endo S, Okada Y, et al. The impact of COVID-19 on thoracic surgical procedures in Japan: analysis of data from the National Clinical Database. Lung Cancer. 2022;172:127–35.
Priou S, Lame G, Zalcman G, Wislez M, Bey R, Chatellier G, et al. Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study. Eur J Cancer. 2022;173:33–40.
Cantini L, Mentrasti G, Russo GL, Signorelli D, Pasello G, Rijavec E, et al. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario. Esmo Open. 2022;7(2): 100406.
Mynard N, Saxena A, Mavracick A, Port J, Lee B, Harrison S, et al. Lung cancer stage shift as a result of COVID-19 lockdowns in New York city, a brief report. Clin Lung Cancer. 2022;23(3):e238–42.
About Coronavirus Disease 2019 (COVID-19). 2023. Available at: https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou.html. Accessed 14 Apr 2023.
Miyata H, Gotoh M, Hashimoto H, Motomura N, Murakami A, Tomotaki A, et al. Challenges and prospects of a clinical database linked to the board certification system. Surg Today. 2014;44(11):1991–9.
The future population estimates in Japan. 2022. Available at: https://www8.cao.go.jp/kourei/whitepaper/w-2012/zenbun/s1_1_1_02.html.
Gupta S, Batt J, Bourbeau J, Chapman KR, Gershon A, Granton J, et al. Triaging access to critical care resources in patients with chronic respiratory diseases in the event of a major COVID-19 surge: key highlights from the Canadian thoracic society (CTS) position statement. Chest. 2020;158(6):2270–4.
Englum BR, Prasad NK, Lake RE, Mayorga-Carlin M, Turner DJ, Siddiqui T, et al. Impact of the COVID-19 pandemic on diagnosis of new cancers: a national multicenter study of the Veterans Affairs Healthcare System. Cancer. 2021;06:06.
Doan C, Li S, Goodwin JS. Breast and lung cancer screening among medicare enrollees during the COVID-19 pandemic. JAMA Netw Open. 2023;6(2):e2255589.
Foundation for Promotion of Cancer Research. Cancer statistics in Japan 2021. Journal [serial online]. 2021. https://ganjoho.jp/public/qa_links/report/statistics/2021_en.html. Accessed 25 Feb 2022.
National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395–409.
Horinouchi H, Kusumoto M, Yatabe Y, Aokage K, Watanabe S, Ishikura S. Lung cancer in Japan. J Thoracic Oncol. 2021;17(3):353–61.
Sagawa M, Nakayama T, Tsukada H, Nishii K, Baba T, Kurita Y, et al. The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan. Lung Cancer. 2003;41(1):29–36.
Zuniga PVS, Ost DE. Impact of delays in lung cancer treatment on survival. Chest. 2021;160(5):1934–58.
Samson P, Patel A, Garrett T, Crabtree T, Kreisel D, Krupnick AS, et al. Effects of delayed surgical resection on short-term and long-term outcomes in clinical stage I non-small cell lung cancer. Ann Thoracic Surg. 2015;99(6):1906–12.
Mayne NR, Elser HC, Darling AJ, Raman V, Liou DZ, Colson YL, et al. Estimating the impact of extended delay to surgery for stage I non-small-cell lung cancer on survival. Ann Surg. 2021;273(5):850–7.
Acknowledgements
We appreciate reviewing and editing the manuscript by F. Miyamasu, Medical English Communications Center, University of Tsukuba.
Funding
MHLW Special Research Program (Grant number JPMH20CA2046) supported this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare the following financial interests/personal relationships, which may be deemed potential competing interests: Hiroyuki Yamamoto is affiliated with the Department of Healthcare Quality Assessment of the University of Tokyo. The department is a social collaboration department supported by grants from the National Clinical Database, Intuitive Surgical Sarl, Johnson & Johnson K.K., and Nipro Co. Hidetaka Uramoto received honoraria for AstraZeneca Co., Ltd., and Chugai Pharmaceutical Co., Ltd. No other conflicts of interest concerning this study are declared by the other authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sato, Y., Yamamoto, H., Ikeda, N. et al. The consecutive impact of COVID-19 on thoracic surgical procedures in Japan: an analysis of data from the National Clinical Database. Surg Today 54, 627–633 (2024). https://doi.org/10.1007/s00595-023-02763-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-023-02763-0